Innovative Healthcare Startup XARlabs Secures $2.3 Million Seed Funding for Mixed Reality Advancements

XARlabs Secures $2.3 Million in Seed Funding

Date: February 10, 2025
Location: London, UK

XARlabs, a pioneering company in the realm of high-precision mixed reality technology catering to the surgical lifecycle, has announced its successful closing of a seed funding round worth $2.3 million. This pivotal financing round was led by renowned technology executive and angel investor Eric Johnson, alongside significant backing from EKA Ventures and a collective of other respected angel investors. Following this funding, Johnson, along with celebrated commercial executive Jacqui Rock, will be joining the Board of Directors at XARlabs.

The raised funds will accelerate XARlabs' ambitions to expand the reach of its flagship product, simXAR, into the international market while enhancing the platform to transform surgical training and real-time visualization through state-of-the-art mixed reality technology.

XARlabs has developed an innovative platform that provides a cost-effective yet high-fidelity alternative to existing tools that are currently prevalent in the mixed reality surgical planning and guidance sectors. The technology employs marker-less tracking capabilities to deliver exceptional precision and creates a fully immersive three-dimensional environment. This allows for collaborative surgical planning and medical education, pushing the limits of what's achievable within the healthcare landscape.

Eric Johnson expressed his enthusiasm about XARlabs' vision, stating, "The capability of mixed reality to address complex medical scenarios presents an exceptional opportunity for reshaping healthcare. My extensive experience in steering early-stage technology initiatives has underscored the vital elements that constitute a thriving business. I am convinced that the strategic trajectory and innovative approach of XARlabs stand out in today's market, and I am eager to assist the company in its journey towards sustained success."

XARlabs' inaugural product, simXAR, is reshaping how surgical visualization operates by using high-precision mixed reality technology. It transforms conventional 2D medical imagery into immersive 3D simulations, allowing for optimized surgical planning, education, and guidance. As the first software of its kind, simXAR is uniquely equipped to provide both trackerless marking and on-device rendering. This revolutionary tool enables healthcare professionals to make precise and timely decisions while simultaneously reducing costs and improving access across various medical settings.

Jacqui Rock shared her excitement on joining XARlabs at a transformative moment in the company’s progression, stating, "XARlabs’ innovative methods and dedication to achieving impactful outcomes resonate perfectly with my values. I look forward to utilizing my experience to further enhance XARlabs’ mission and create lasting impacts."

Building on an impressive year marked by significant achievements—including the integration of simXAR at a National Health Service (NHS) hospital and key involvement in planning a notable conjoined twins separation—XARlabs is poised to broaden its product usage globally.

XARlabs' CEO, Ali Haddad, expressed his delight at welcoming both Jacqui and Eric to the leadership team, citing their extensive expertise in large-scale innovation and strategic leadership as vital assets for increasing the company's prospects. "The confidence investors show along with the rising global demand for mixed reality solutions in healthcare positions XARlabs for remarkable success," Haddad remarked. He also highlighted that this milestone underscores XARlabs' commitment to redefining surgical planning and education through mixed reality technologies, aiming to deliver these advancements into operating rooms and medical institutions worldwide.

About XARlabs

XARlabs is at the forefront of healthcare transformation through its advanced mixed reality solutions designed to elevate surgical planning, medical education, and clinical collaboration. The company's flagship product, simXAR, utilizes advanced marker-less tracking and immersive 3D modeling to facilitate unparalleled anatomical visualization and hands-on training. Founded by Dr. Ali Haddad, a neurosurgeon and NHS Clinical Entrepreneur, XARlabs operates out of London, UK. Its groundbreaking platform has already been instrumental in pioneering medical procedures at leading hospitals, solidifying the company's position as a leader in surgical innovation and mixed reality applications within healthcare.

For more information, visit XARlabs.